This illustration provided by AstraZeneca depicts packaging for their medication Beyfortus. U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year. The Food and Drug Administration on Monday, July 17, 2023 approved the injection for infants and children up to 2 years old. (AstraZeneca via AP)
By Matthew Perrone
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.
“Today’s approval addresses the great need for products to help reduce the impact of RSV disease on children, families and the health care system” said FDA's Dr. John Farley in a statement.
Last year, a surge in RSV cases flooded U.S. hospitals with wheezing children. There are no vaccines for babies yet, though Pfizer and other companies are working on them.
AstraZeneca’s drug, to be sold under the brand name Beyfortus, is a laboratory-made version of an antibody that helps the immune system fight off RSV. Under the FDA approval, babies — including preterm infants — can receive a single injection to protect against their first season of RSV, which typically lasts about five months. Children up to age 2 can receive another dose to protect them during their second season facing the virus.
Beyfortus, which will be marketed in the U.S. by Sanofi, is already approved in Canada, Europe and the U.K. Sanofi did not immediately announce the U.S. price of the treatment.
FDA officials approved the drug based on three studies showing Beyfortus reduced the risk of RSV infection between 70% and 75% among infants and children 2 and younger.
Advisers to the Centers for Disease Control and Prevention will meet early next month to recommend exactly who should get the drug.
A similar antibody drug won FDA approval more than 20 years ago, but it’s only recommended for high-risk babies and requires monthly injections. Pediatricians say the drug is underutilized and they expect the longer-lasting effect of AstraZeneca's shot to improve uptake.
In the U.S., about 58,000 children younger than 5 are hospitalized for RSV each year and several hundred die.
After decades of setbacks for RSV research, drugmakers have made big strides this year, launching the first vaccines against the virus. In May, the FDA approved two RSV vaccines for older adults from GlaxoSmithKline and Pfizer. In August, the FDA is expected to make a decision on approving Pfizer’s vaccine for pregnant women, with the aim of passing along protection to their newborns.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
Catching you up on what you need to know on April 26, 2022, with Elon Musk’s purchase of Twitter for $44 billion, Russia warning of a possible threat of World War III, the FDA approving a COVID treatment for children under 12, and more.
Plastic pollution is a problem that experts say is only getting worse. One organization is looking to change that. Activists want to save the beauty of our oceans, with the beauty of art. Brad Parks, conservation education director of the Washed Ashore project, joins Cheddar News to discuss.
The federal mask mandate for planes and other public transportation has been grounded. A federal judge in Florida struck down the nationwide requirement saying it exceeds health officials' authority. Dr. Sampson Davis, emergency medicine physician, joins Cheddar News to discuss.
UPSIDE foods, a company that makes cultivated meat products, recently raised $400 million in a Series C round.
UPSIDE says it's developing a way to grow real meat, poultry, and seafood, without the need to raise animals for human consumption. It's a process that gets the attention of some big-name backers, including Bill Gates and Richard Branson. Dr. Uma Valeti, Founder and CEO of UPSIDE Foods, joins Cheddar News' Closing Bell to discuss.
Catching you up on what you need to know on April 25, 2022, with Secretary of State Blinken and Defense Secretary Austin visiting Ukraine, Emmanuel Macron is reelected as president of France, Twitter is talking to Elon Musk about his purchase bid, and more.
An increasing number of countries are recognizing "Rights of Nature", a legal movement that says ecosystems and species have basic rights to exist and flourish. Grant Wilson, executive director at Earth Law Center joins Cheddar News to explain what the movement is aiming to achieve.
Removing carbon from our atmosphere has become a goal for scientists and entrepreneurs around the world, and while many have begun to develop promising technology solutions, a few big names in tech, including Stripe, Alphabet, Shopify, Meta and McKinsey, are committing nearly $1 billion dollars to fund carbon removal technology through 2030 through a new initiative called Frontier, an advanced market commitment to incentive following through on development. Hannah Bebbington, the head of strategy for Frontier, joined Cheddar News to discuss. "What Frontier aims to do is help get this market on track by sending that strong demand signal such that we can scale up capacity really significantly in the next couple of years," she said.
Autumn Peltier, an indigenous water activist, joined Cheddar News to talk about the lack of access to clean water among indigenous communities in Canada. “I say the government to hold themselves accountable for the promises that they make because Canada and indigenous people have a long history of broken promises and they still continue to this day to keep breaking promises with the nation's people," she said. "Less talk and more action is very much expected from me."
Jonah Goldman, the managing director at Bill Gates-founded Breakthrough Energy, joined Cheddar News to talk about the promising growth in the climate change-conscious investments the organization has made over the years. ”I mean when we're looking at some of the hard to abate technologies and cement and steel and aviation fuel, all of those have promising pathways that weren't there again just a few years ago," he said. "We invest across all of the technology areas that are driving emissions, greenhouse gas emissions and there really are exciting products and technologies coming out in almost every one of those sectors.”
Robert Bonnie, farm production and conservation undersecretary for the USDA, spoke to Cheddar about climate-smart strategies to help farmers reduce carbon emissions from agriculture. "We share the costs of installing those practices on their lands in ways that will protect the climate and maintain agricultural productivity, and we're also partnering with farmers to draw in private investment in greenhouse gas emissions reductions provided by agriculture and forestry," he said. The hope is to get farmers and ranchers to produce climate-smart commodities to lessen the impact of climate change.
